DXCM
Dexcom Inc
$84.46-4.54%
Setup
No setup
Buy Zone
$86.45-$90.77
Sector
Medical Devices
Industry
Medical Devices
51
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
DXCM chart
Loading chart…
ADX
Weak or Absent16.9Long Term
Up ↑Intermediate Term
Up ↑Short Term
Range →Overall Quality51
RS Rating
82
relative strength
Fundamentals
58
Weak fund-Q
Volume Demand
68
+12% vs avg
Technical Setup
50
4/8 checks
Industry/Theme
91
Medical Devices
Trade Plan
Avoid
Entry
$86.45
Entry Zone
$86.45-$90.77
Stop / Risk
$79.53
RS Rating
82
Volume confirmed
No
Targets
$103.74 / $108.06
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $86.45–$90.77Stop $79.53Target $103.74 / $108.06
Market regimeRange
Quality51
RS Rating82
Above 50-MA-1.11%
Above 200-MA+12.83%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
51
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q58 · Weak
StatusAvoid
Stock Data
52-Week Range54 – 93
Price % Chg YTD27.26%
Price % Chg 4wk0.19%
50-Day Avg Vol4.4 Mil
P/E Ratio32.3
Market Cap$31B
SectorHealthcare
IndustryMedical Devices
Company Fundamentals
EPS % Chg (Qtr)2.56%
Sales % Chg (Qtr)11.18%
EPS Growth 5y10.55%
Sales Growth 5y19.33%
Annual ROE37.67%
Gross Margin64.18%
Operating Margin23.98%
Net Margin19.41%
Debt / Equity0.55
Setup levels
Current price
$84.46
Pivot
$86.45
Distance to buy
-8.8%
52-week range
54.11-92.59
Trigger evidence
No active trigger evidence available.
Financial health checks
5/5
Return on equity above 15%
ROE 37.67%
Net margin above 10%
Net margin 19.41%
EPS growing quarter on quarter
EPS q/q 2.56%
Sales growing quarter on quarter
Sales q/q 11.18%
Debt to equity below 1.0
D/E 0.55
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE37.67%
vs sector +15.1%
Net margin19.41%
vs sector +1.7%
Gross margin64.18%
vs sector -3.0%
EPS growth q/q2.56%
vs sector -5.0%
Sales growth q/q11.18%
vs sector -7.5%
Debt / equity0.55
vs sector -0.10
Business quality
58
GradeWeak
EPS rating35
P/E32.3
Market cap$31B
IndustryMedical Devices
Technical checks
Über 50-MA
Fail
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-01
Trigger date
—
Days on list
5
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.